Week of April 9, 2024 | Vol. 13, Issue 15

In This Issue

Upcoming Events

Industry Activity

Market Research

M&A Pipeline

Featured Headlines

Recent Transactions

Contact

Xan Smith

Managing Director, Private Equity Coverage & Origination


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

About
Research

Industry Snapshot

Upcoming Events

Wells Fargo Championship

May 6-12, 2024 | Quail Hollow Club, Charlotte, NC

124th U.S. Open

June 10-16 | Pinehurst, NC

Let's Meet!

Industry Activity

M&A Transactions

Pharma & Biotech

13 transactions totaling $906 million


Supplies, Equipment & Services

11 transactions totaling $15,375 million


Healthcare Facilities & Distributors

6 transactions totaling $61 million


Healthcare IT & Managed Care

3 transactions

Featured Chart

Trading Comps

Market Research

Bourne Brief

5 Drivers of the PRV Market


Capital Markets Update

2024 Outlook


Bourne Brief

Navigating Tailwinds & Headwinds in Clinical Research Service


Market Insight

Biostorage Services Report


Market Insight

Using Divestitures to Deliver Excess Returns

More Research

M&A Pipeline

Project Ester

Consumer Health - Strategic Partnering | Contact: Robert Stanley

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Trident

Pharma - Buy-Side | Contact: Robert Stanley

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Project Bison

Pharma Support Services - Sell-Side | Contact: Todd Bokus

Acquisition opportunity of a CQV, calibration & metrology, and other pharma support services platform

Project Panther

Pharma Services - Sell-Side | Contact: Jake Curtis

Acquisition opportunity of OTC and personal care CDMO

Project Ignatius

Pharma Services - Sell-Side | Contact: Jake Curtis

Acquisition opportunity of Phase I clinical research site

Project Nirvana

Pharma - Capital Raise | Contact: Carson Riley

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Featured Headlines

With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO

Fierce Pharma

Acquisition expands Bora’s North American footprint with first US manufacturing site

Bora Pharmaceuticals

Invenra Inc. Announces a Strategic Collaboration with Catalent to Co-Discover Novel Bispecific ADCs

Business Wire

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease

Globe Newswire

Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs

Bespak

Lindus launches 'all-in-one' CRO for respiratory clinical trials

Fierce Biotech

Ship of Theseus Taps Charles River as Manufacturing Partner

Contract Pharma

Clario buys AI firm ArtiQ, taps CEO to head AI strategy

Fierce Biotech

Recent Transactions

Bourne continues to be one of the most active Pharma Services Advisors, having closed 7 transactions with 7 different sponsors within the last 45 days with more to come! Select recent clients and counterparties include:

LinkedIn  Web